These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Vascular endothelial growth factor-targeted therapies in advanced renal cell carcinoma. Albiges L; Salem M; Rini B; Escudier B Hematol Oncol Clin North Am; 2011 Aug; 25(4):813-33. PubMed ID: 21763969 [TBL] [Abstract][Full Text] [Related]
6. Toxicities of targeted agents in advanced renal cell carcinoma. Patel P; Srinivas S Curr Clin Pharmacol; 2011 Aug; 6(3):181-8. PubMed ID: 21827392 [TBL] [Abstract][Full Text] [Related]
7. VEGF inhibitors in renal cell carcinoma. Vachhani P; George S Clin Adv Hematol Oncol; 2016 Dec; 14(12):1016-1028. PubMed ID: 28212363 [TBL] [Abstract][Full Text] [Related]
8. Targeted therapy for metastatic renal cell carcinoma: a home run or a work in progress? Rini BI; Bukowski RM Oncology (Williston Park); 2008 Apr; 22(4):388-96; discussion 396, 402-3, 476 passim. PubMed ID: 18472614 [TBL] [Abstract][Full Text] [Related]
9. Targeted therapy in renal cell carcinoma. Favaro JP; George DJ Expert Opin Investig Drugs; 2005 Oct; 14(10):1251-8. PubMed ID: 16185167 [TBL] [Abstract][Full Text] [Related]
10. The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma. Choueiri TK; Bukowski RM; Rini BI Semin Oncol; 2006 Oct; 33(5):596-606. PubMed ID: 17045089 [TBL] [Abstract][Full Text] [Related]
11. Bevacizumab as a treatment option in advanced renal cell carcinoma: an analysis and interpretation of clinical trial data. McDermott DF; George DJ Cancer Treat Rev; 2010 May; 36(3):216-23. PubMed ID: 20116176 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor and mTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms. Mulders P BJU Int; 2009 Dec; 104(11):1585-9. PubMed ID: 20053190 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-targeted therapy for the treatment of renal cell carcinoma. Escudier B; Albiges L Drugs; 2011 Jun; 71(9):1179-91. PubMed ID: 21711062 [TBL] [Abstract][Full Text] [Related]
14. Treatment of renal cell carcinoma: Current status and future directions. Barata PC; Rini BI CA Cancer J Clin; 2017 Nov; 67(6):507-524. PubMed ID: 28961310 [TBL] [Abstract][Full Text] [Related]
15. Advanced renal cell carcinoma: current and emerging management strategies. Escudier B Drugs; 2007; 67(9):1257-64. PubMed ID: 17547470 [TBL] [Abstract][Full Text] [Related]
16. Systemic therapy for metastatic renal cell carcinoma in treatment naïve patients: a risk-based approach. Bukowski RM Expert Opin Pharmacother; 2010 Oct; 11(14):2351-62. PubMed ID: 20586712 [TBL] [Abstract][Full Text] [Related]